Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | NPY2R | P49146 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19995826 | 0.84 | HPGD (0.47) | SMN1; SMN2MEN1KMT2A | |
| SCHEMBL3270029 | 0.77 | SMN1; SMN2 (0.39) | CYP2D6KCNH2HRH3SMN1; SMN2LMNA | |
| SCHEMBL1049997 | 0.76 | CYP2D6 (0.40) | CYP2D6KCNH2HRH3SMN1; SMN2LMNA | |
| SCHEMBL2213404 | 0.73 | MAPT (0.38) | SMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL5765556 | 0.72 | CYP2D6 (0.55) | CYP2D6KCNH2HRH3SMN1; SMN2LMNA | |
| SCHEMBL14734853 | 0.71 | NPC1 (0.42) | MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL29034671 | 0.70 | CYP2D6 (0.53) | CYP2D6KCNH2HRH3SMN1; SMN2LMNA | |
| SCHEMBL5076729 | 0.70 | MAPT (0.36) | — | |
| SCHEMBL4476428 | 0.69 | CYP2D6 (0.38) | CYP2D6KCNH2HRH3LMNANPY2R | |
| SCHEMBL28697491 | 0.69 | NPY2R (0.34) | CYP2D6KCNH2HRH3SMN1; SMN2NPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3768666-A1 | COMPOUNDS AND METHODS FOR IDO AND TDO MODULATION, AND INDICATIONS THEREFOR | Plexxikon Inc. (US) | 2021-01-27 | — | — | EP | disclosed |
| CN-112119072-A | Compounds and methods for IDO and TDO modulation, and indications thereof | 普莱希科公司 | 2020-12-22 | — | — | CN | disclosed |
| WO-2019183145-A1 | COMPOUNDS AND METHODS FOR IDO AND TDO MODULATION, AND INDICATIONS THEREFOR | PLEXXIKON INC. (US) | 2019-09-26 | — | — | WO | disclosed |